Literature DB >> 15382264

Discovery of high-affinity peptide binders to BLyS by phage display.

Tony J Fleming1, Meena Sachdeva, Marko Delic, James Beltzer, Charles R Wescott, Mary Devlin, Robert C Lander, Andrew E Nixon, Viktor Roschke, David M Hilbert, Daniel J Sexton.   

Abstract

B lymphocyte stimulator (BLyS) is a tumor necrosis factor (TNF) family member and a key regulator of B cell responses. We employed a phage display-based approach to identify peptides that bind BLyS with high selectivity and affinity. Sequence analysis of first-generation BLyS-binding peptides revealed two dominant peptide motifs, including one containing a conserved DxLT sequence. Selected linear peptides with this motif were found to bind BLyS with K(D) values of 1-3 microM. In order to improve the binding affinity for BLyS, consensus residues flanking the DxLT sequence were seeded into a second-generation, BLyS affinity maturation library (BAML). BAML phage were subjected to stringent binding competition conditions to select for isolates expressing high-affinity peptide ligands for BLyS. Post-selection analysis of BAML peptide sequences resulted in the identification of a core decapeptide motif (WYDPLTKLWL). Peptides containing this core motif exhibited K(D) values as low as 26 nM, approximately 100-fold lower than that of first-generation peptides. A fluorescence anisotropy assay was developed to monitor the protein-protein interaction between BLyS labeled with a ruthenium chelate, and TACI-Fc, a soluble form of a BLyS receptor. Using this assay it was found that a BAML peptide disrupts this high-affinity protein-protein interaction. This demonstrates the potential of short peptides for disruption of high affinity cytokine-receptor interactions. Copyright 2004 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15382264     DOI: 10.1002/jmr.722

Source DB:  PubMed          Journal:  J Mol Recognit        ISSN: 0952-3499            Impact factor:   2.137


  9 in total

1.  Mapping of Taenia solium TSOL18 antigenic epitopes by phage display library.

Authors:  Aijiang Guo; Xuepeng Cai; Wanzhong Jia; Bing Liu; Shaohua Zhang; Peiya Wang; Hongbing Yan; Xuenong Luo
Journal:  Parasitol Res       Date:  2010-02-23       Impact factor: 2.289

2.  Molecular fluorescence, phosphorescence, and chemiluminescence spectrometry.

Authors:  Kristin A Fletcher; Sayo O Fakayode; Mark Lowry; Sheryl A Tucker; Sharon L Neal; Irene W Kimaru; Matthew E McCarroll; Gabor Patonay; Philip B Oldham; Oleksandr Rusin; Robert M Strongin; Isiah M Warner
Journal:  Anal Chem       Date:  2006-06-15       Impact factor: 6.986

3.  Identification of binding peptides of the ADAM15 disintegrin domain using phage display.

Authors:  Jing Wu; Min-Chen Wu; Lian-Fen Zhang; Jian-Yong Lei; Lei Feng; Jian Jin
Journal:  J Biosci       Date:  2009-06       Impact factor: 1.826

4.  Bacterial display enables efficient and quantitative peptide affinity maturation.

Authors:  Sophia A Kenrick; Patrick S Daugherty
Journal:  Protein Eng Des Sel       Date:  2010-01       Impact factor: 1.650

5.  B-lymphocyte stimulator (BLyS) stimulates immunoglobulin production and malignant B-cell growth in Waldenstrom macroglobulinemia.

Authors:  Sherine F Elsawa; Anne J Novak; Deanna M Grote; Steven C Ziesmer; Thomas E Witzig; Robert A Kyle; Stacey R Dillon; Brandon Harder; Jane A Gross; Stephen M Ansell
Journal:  Blood       Date:  2005-11-22       Impact factor: 22.113

6.  Potential of phage-displayed peptide library technology to identify functional targeting peptides.

Authors:  Lauren Rh Krumpe; Toshiyuki Mori
Journal:  Expert Opin Drug Discov       Date:  2007-04       Impact factor: 6.098

Review 7.  Role of BAFF and APRIL in human B-cell chronic lymphocytic leukaemia.

Authors:  Stéphanie Haiat; Christian Billard; Claire Quiney; Florence Ajchenbaum-Cymbalista; Jean-Pierre Kolb
Journal:  Immunology       Date:  2006-07       Impact factor: 7.397

8.  The Use of Phage-Displayed Peptide Libraries to Develop Tumor-Targeting Drugs.

Authors:  Lauren R H Krumpe; Toshiyuki Mori
Journal:  Int J Pept Res Ther       Date:  2006-03-03       Impact factor: 1.931

Review 9.  Epitope mapping: the first step in developing epitope-based vaccines.

Authors:  Jonathan M Gershoni; Anna Roitburd-Berman; Dror D Siman-Tov; Natalia Tarnovitski Freund; Yael Weiss
Journal:  BioDrugs       Date:  2007       Impact factor: 5.807

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.